Files and links (1)
Published (Version of record)CC BY V4.0, Open Access
- Title
- The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
- Creators
- Izumi Kimura - The University of TokyoYusuke Kosugi - The University of TokyoJiaqi Wu - Kyoto UniversityJiri Zahradnik - 972WIS_INST___112Daichi Yamasoba - The University of TokyoErika P Butlertanaka - University of MiyazakiYuri L Tanaka - University of MiyazakiKeiya Uriu - The University of TokyoYafei Liu - Osaka UniversityNanami Morizako - University of MiyazakiKotaro Shirakawa - Kyoto UniversityYasuhiro Kazuma - Kyoto UniversityRyosuke Nomura - Kyoto UniversityYoshihito Horisawa - Kyoto UniversityKenzo Tokunaga - National Institute of Infectious DiseasesTakamasa Ueno - Kumamoto UniversityAkifumi Takaori-Kondo - Kyoto UniversityGideon Schreiber - 972WIS_INST___112Hisashi Arase - The University of TokyoAkatsuki Saito - University of MiyazakiChihiro Motozono - Kumamoto UniversitySo Nakagawa (Corresponding Author) - Tokai UniversityKei Sato (Corresponding Author) - The University of Tokyo
- Resource Type
- Journal article
- Publication Details
- Cell reports (Cambridge), Vol.38(2), p.110218; Dec/2021
- Number of pages
- 20
- Language
- English
- DOI
- https://doi.org/10.1016/j.celrep.2021.110218
- Grant note
- We would like to thank all of the members belonging to The Genotype to Phenotype Japan (G2P-Japan) Consortium. The supercomputing resource was provided by Human Genome Center at the University of Tokyo and the NIG supercomputer at ROIS National Institute of Genetics. We thank Dr. Masafumi Takiguchi (Kumamoto University, Japan) for providing C1R-A2402 cells. This study was supported in part by the AMED Research Program on Emerging and Re-emerging Infectious Diseases 20fk0108539 (to T.U.), 20fk0108542 and 20fk0108403 (to H.A.), 20fk0108163 and 20fk0108518 (to A.S.), 20fk0108146 and 20fk0108270 (to K. Sato), 20fk0108413 (to S.N. and K. Sato), and 20fk0108451 (to G2P-Japan Consortium, T.U., A.T.-K., A.S., S.N. and K. Sato); the AMED Research Program on HIV/AIDS 21fk0410046 (to C.M.), 21fk0410033 (to A.S.), and 21fk0410039 (to K. Sato); the AMED Japan Program for Infectious Diseases Research and Infrastructure 20wm0325009 and 21wm0325009 (to A.S.); JST SICORP (e-ASIA) JPMJSC20U1 (to K. Sato); JST SICORP JPMJSC21U5 (to K.Sato); JST CREST JPMJCR20H6 (to S.N.) and JPMJCR20H4 (to K. Sato); JSPS KAKENHI Grant-in-Aid for Scientific Research C 18K07156 and 21K07060 (to K.T.), Scientific Research S 18H05279 (to H.A.), Scientific Research C 19K06382 (to A.S.), and Scientific Research B 18H02662 (to K. Sato) and 21H02737 (to K. Sato); the JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research) 18KK0447 (to K. Sato); the JSPS Core-to-Core Program JPJSCCA20190008 (A. Advanced Research Networks) (to K. Sato); the JSPS Research Fellow DC1 19J20488 (to I.K.); the Ono Medical Research Foundation (to K. Sato); the Ichiro Kanehara Foundation (to K. Sato); the Lotte Foundation (to K. Sato); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to K. Sato); the Daiichi Sankyo Foundation of Life Science (to K. Sato); the Sumitomo Foundation (to K. Sato); the Uehara Foundation (to K. Sato); the Takeda Science Foundation (to C.M. and K. Sato); The Tokyo Biochemical Research Foundation (to K. Sato); a Grant for Joint Research Projects of the Research Institute for Microbial Diseases, Osaka University (to A.S.); an intramural grant from Kumamoto University COVID-19 Research Projects (AMABIE) (to C.M.); and the Joint Usage/Research Center Program of Institute for Frontier Life and Medical Sciences, Kyoto University (to K. Sato).
- Record Identifier
- 993335815703596